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Abstract
Background: Previous reports indicate that ethanol, in a binge drinking model in mice, inhibits the
production of pro-inflammatory cytokines in vivo. However, the inhibition of signaling through
TLR4 has not been investigated in this experimental model in vivo. Considering evidence that
signaling can be very different in vitro and in vivo, the present study was conducted to determine
if effects of ethanol on TLR4 signaling reported for cells in culture or cells removed from ethanol
treated mice and stimulated in culture also occur when ethanol treatment and TLR4 activation
occur in vivo.
Results: Phosphorylated p38, ERK, and c-Jun (nuclear) were quantified with kits or by western blot
using samples taken 15, 30, and 60 min after stimulation of peritoneal macrophages with
lipopolysaccharide in vivo. Effects of ethanol were assessed by administering ethanol by gavage at
6 g/kg 30 min before administration of lipopolysaccharide (LPS). Cytokine concentrations in the
samples of peritoneal lavage fluid and in serum were determined at 1, 2, and 6 hr after
lipopolysaccharide administration. All of these data were used to measure the area under the
concentration vs time curve, which provided an indication of the overall effects of ethanol in this
system. Ethanol suppressed production of most pro-inflammatory cytokines to a similar degree as
it inhibited key TLR4 signaling events. However, NF-B (p65) translocation to the nucleus was not
inhibited by ethanol. To determine if NF-B composed of other subunits was inhibited, transgenic
mice with a luciferase reporter were used. This revealed a reproducible inhibition of NF-B activity,
which is consistent with the observed inhibition of cytokines whose expression is known to be NF-
B dependent.
Conclusion: Overall, the effects of ethanol on signalling in vivo were similar to those reported for
in vitro exposure to ethanol and/or lipopolysaccharide. However, inhibition of the activation of NF-
B was not detected as translocation of p65 to the nucleus but was detected using transgenic
reporter mice. The observation that ethanol given 24 hr before dosing with LPS modulated
production of some cytokines indicates a persistent effect which does not require continued
presence of ethanol.
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Background
Acute ethanol exposure can suppress signaling through
toll-like receptors (TLR). This signaling normally leads to
the production of pro-inflammatory cytokines [1-3].
However, studies of this matter have been performed
using macrophage-like cell lines or human monocytes fol-
lowing in vitro exposure to ethanol and an inflammatory
stimulus, or using macrophages from ethanol-treated
mice stimulated ex vivo. A number of studies in the past
several years demonstrate that signaling can be remarka-
bly different in vitro (or ex vivo) and in vivo, even when
using the same stimulus [4-6]. In addition, we found that
the pattern of IL-10 and IL-12 production was very differ-
ent in a macrophage-like cell line in vitro and in the peri-
toneal cavity or serum in vivo [7]. Therefore, it is
important to confirm that the inhibition of TLR4-medi-
ated signaling by ethanol that has been reported in vitro
and ex vivo also occurs when both ethanol and the TLR4
agonist are administered in vivo and the signaling events
occur in vivo. In most cases, signaling cannot be evaluated
using freshly isolated cells because of the transient nature
of signaling and the time required to purify the desired
cell type from the complex mixture of cells found in lym-
phoid organs, tissues, or blood. However, we reported
previously that B6C3F1 mice have a population of resi-
dent cells in the peritoneal cavity that are >85% macro-
phages [8]. These cells can be obtained very quickly,
placed on ice and extracted within a few minutes, thus
allowing cellular signaling studies to be conducted using
cells in which cellular signaling and any inhibition of that
signaling actually occurred in the experimental animal.
This approach is utilized here to quantitatively assess the
effects of ethanol on signaling over time and cytokine pro-
duction over time.
The mitogen activated protein (MAP) kinase pathway
seems particularly important in TLR4 signaling [9], so key
members of this group, ERK and p38, were evaluated.
Among several transcription factors activated by TLR4 sig-
naling, AP-1 and NF-B are required for expression of sev-
eral of the cytokines that are inhibited by ethanol (e.g., IL-
6, TNF-, and IL-12) [10-12]. Therefore, activation of
these transcription factors was evaluated. Assessment of
immunological parameters at only one point in time can
yield results that are not at all representative of the overall
effects over time. In the present study phoshphorylated
(activated) ERK and p38 as well as phosphorylated c-Jun
(a component of the AP-1 transcription factor) and
nuclear p65 (as an indicator of NF-B activation) were
evaluated over the course of time and the area under the
concentration vs time curve was calculated as an indicator
of the overall difference in signaling over time. Similarly,
cytokine concentrations in the peritoneal cavity were
quantified over time. We have previously shown that IL-6
(as a representative pro-inflammatory cytokine) obtained
by peritoneal lavage is not derived primarily from blood
but produced locally [13], probably by the peritoneal
macrophages in which signaling was evaluated.
The results generally confirmed previous reports of inhibi-
tion of signaling beginning early in the TLR4 signaling
pathway and extending to the ends of the pathway, the
activated transcription factors. However, there was no
indication of inhibition of p65 translocation into the
nucleus, suggesting that ethanol does not inhibit NF-B
activation. However, to insure that activation mediated by
NF-B proteins that do not contain p65 was also not
inhibited, transgenic mice with an NK-B luciferase
reporter construct were evaluated by luminescence imag-
ing in live anesthetized mice.
Results
Effects of ethanol on activation of MAP kinases, AP-1, and 
NF-B
In a previous study, we reported that ethanol alone at the
same dosage and timing as used in the present study does
not induce increases in the production of IL-6, IL-10, or
IL-12 [13]. Thus, it seemed likely that "ethanol only" con-
trols would not be informative, so they were not included.
Data shown in Figure 1 indicate that activation of AP-1 (as
indicated by phosphorylation and nuclear translocation
of c-Jun, one of the components of AP-1) was suppressed
by ethanol, and suppression was maximal at 30 min.
Results shown in Figure 2 indicate that activation (as indi-
cated by phosphorylation) of kinases upstream of these
transcription factors were significantly inhibited and that
the inhibition of p-c-Jun shown in Figure 1 was also sig-
nificant at 30 min. Suppression was significant (by Stu-
dent's t test) for at least one time point for all kinases, and
suppression of p-p38 was almost significant at 30 min.
Phosphorylation had decreased to unstimulated levels
within 1 hr, indicating that the role of these signaling
mediators was completed in that time and the area under
the concentration vs. time curve in this study reflects the
complete period of signaling. The area under the concen-
tration vs. time curve values are shown in Table 1. As
would be expected on the basis of the graphs in Figure 2,
ethanol suppressed the AUC values in all cases. The acti-
Table 1: AUC Values for signaling and cytokine production
LPS LPS + Ethanol Ratio
p-p38 190694 106858 0.56
p-ERK 175677 129677 0.74
p-c-jun 33 5 0.15
IL-6 12885 4829 0.37
IL-12 1601 669 0.42
TNF- 65 12 0.19
IL-1 77 40 0.51BMC Immunology 2009, 10:49 http://www.biomedcentral.com/1471-2172/10/49
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vation of p-c-Jun was inhibited to a greater extent than p-
p38 or p-ERK, and peritoneal cytokines were inhibited to
varying degrees, but the ratio of LPS + ethanol to LPS
groups was within the range of the values noted for sign-
aling parameters, except that p-ERK was inhibited less
than any of the cytokines in which ERK is involved in sig-
naling. Assessing signaling in peritoneal macrophages and
cytokines produced by these cells in the peritoneal cavity
allows assessment of these parameters following a repre-
sentative in vivo innate inflammatory response. The
results are consistent with the idea that inhibition of sign-
aling contributes to inhibition of cytokine production.
Results shown in Figure 3 indicate that LPS causes sub-
stantial activation of NF-B, as indicated by translocation
of p65 to the nucleus. Ethanol did not significantly inhibit
this activation. However, it remained possible that other
forms of NF-B were inhibited by ethanol, so that overall
inhibition of NF-B could contribute to inhibition of the
induction of cytokines. Therefore, transgenic mice with an
NF-B responsive luciferase reporter construct were used
to detect activation of all transcription activating forms of
NF-B. Results shown in Figure 4 demonstrate significant
inhibition of NF-B activation by ethanol at 4 or 5 g/kg,
which we have previously reported to produce peak blood
ethanol levels of 200 and 300 mg% (43.5 and 65.2 mM),
respectively [14].
Inhibition of nuclear translocation of transcription factors by  ethanol Figure 1
Inhibition of nuclear translocation of transcription 
factors by ethanol. Mice were treated with ethanol at 6 g/
kg (by gavage with a 32%, v/v solution). Thirty minutes later, 
LPS (60 g/mouse) was administered intravenously. Then at 
the indicated times after LPS administration, peritoneal mac-
rophages were isolated by lavage using ice cold PBS. Nuclear 
extracts were prepared and the indicated proteins assessed 
by western blot. Each lane represents a sample from one 
mouse (n = 2 for naive; n = 4 for most groups; n = 3 for LPS 
+ ethanol at 60 min). Quantitation and statistical analysis of 
these data are shown in Figures 2 and 3.
Activation of signaling molecules induced by LPS in vivo is  inhibited by ethanol Figure 2
Activation of signaling molecules induced by LPS in 
vivo is inhibited by ethanol. Mice were treated with etha-
nol at 6 g/kg (by oral gavage with a 32%, v/v solution). Thirty 
minutes later, LPS (60 g/mouse) was administered intrave-
nously. Then at the indicated times after LPS administration, 
peritoneal macrophages were isolated by gavage using ice 
cold PBS. Cell pellets were immediately extracted and ana-
lyzed for the indicated phosphorylated proteins by western 
blot. Values shown are means ± SEM (n = 5 mice per group). 
Values at each time point for LPS-treated and LPS plus etha-
nol-treated animals were compared by Student's t test and 
significant differences are indicated by ** (p < 0.01).BMC Immunology 2009, 10:49 http://www.biomedcentral.com/1471-2172/10/49
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Effects of ethanol on cytokines in serum over time and 
dependence on time of ethanol administration
Results shown in Figure 5 demonstrate that ethanol inhib-
its the production of most pro-inflammatory cytokines
throughout the time that they are produced in response to
LPS. The dosage used in this study (6 g/kg) yields a peak
blood ethanol concentration of 400 mg% (87 mM) [15].
Such concentrations have been reported in binge drinkers,
but more importantly, inhibition of cytokine production
is dose responsive with effects noted at dosages as low as
3 g/kg, by gavage [16]. Because the duration of the ethanol
action has not previously been determined in this model,
ethanol was administered to different groups 24, 2, and
0.5 hr before administration of LPS (Figures 5 and 6). The
concentration of IL-6 and IL-12 p70 in the serum was sig-
nificantly decreased (p < 0.05) when ethanol was admin-
istered 24, 2, and 0.5 hr before LPS. This 24 hr duration of
effects has not been reported previously and is relevant
with regard to potential increased risk of infection not just
on the day of binge drinking but possibly also the next
Ethanol does not alter the translocation of the p65 compo- nent of NF-B to the nucleus Figure 3
Ethanol does not alter the translocation of the p65 
component of NF-B to the nucleus. Nuclear extracts 
were prepared as described in materials and methods, and 
analyzed by western blot for p65. Values shown represent 
mean pixel density ± SEM (n = 5 mice per group). Values at 
each time point for LPS-treated and LPS plus ethanol-treated 
animals were compared by Student's t test and no significant 
differences were identified.
Ethanol inhibits NF-B reporter construct activation by LPS  in vivo Figure 4
Ethanol inhibits NF-B reporter construct activation 
by LPS in vivo. Transgenic mice with an NF-B reporter 
driving expression of luciferase were imaged using an IVIS 
luminescence imager. Below each image of light emission pro-
files for the mice is a graph in which the data for those mice 
were analyzed using the IVIS software for integrated photon 
emission. Values shown are means ± SEM for the indicated 
group sizes. Values significantly different from the LPS control 
are indicated by ** (p < 0.01).BMC Immunology 2009, 10:49 http://www.biomedcentral.com/1471-2172/10/49
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day. The cytokines significantly suppressed by ethanol at
one or more time points were IL-6, IL-12 p70, IL-12 p40,
and TNF-. The IL-1 response was also decreased, but the
decrease was primarily at 1 hr after LPS. The concentration
of IL-10 was significantly enhanced by treatment with eth-
anol 0.5 or 2 hr before LPS. A similar effect was noted in
mice treated with polyinosinic polycytidylic acid to acti-
vate TLR3 [13]. One unexpected observation was the
enhancement of IL-12 production by ethanol administra-
tion 24 hr before LPS. Previously such an increase had
only been noted for IL-10 [13]. This increase was not
observed for IL-12 p40, but it has been established that
expression of the genes for IL-12 p40 and p35 are regu-
lated independently and both of these proteins are
required for the formation of the p70 heterodimer of IL-
12 [17]. Thus, IL-12 p35 may be the limiting factor in IL-
12 p70 production, and upregulation of IL-12 p35 could
cause increased IL-12 p70 without an increase in IL-12
p40.
Ethanol modulates production of some cytokines in serum, even when administered 24 hr before LPS Figure 5
Ethanol modulates production of some cytokines in serum, even when administered 24 hr before LPS. Mice 
were treated with ethanol (6 g/kg by gavage) at the indicated times before LPS, and blood and peritoneal fluid samples were 
obtained for analysis 2 hr after LPS. Values shown are means ± SEM (n = 5). Because of overlapping values, showing statistical 
results on the graphs is not practical. Major statistically significant outcomes are identified in the text of the results section.BMC Immunology 2009, 10:49 http://www.biomedcentral.com/1471-2172/10/49
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Effects of ethanol on cytokines in the peritoneal cavity 
over time and dependence on time of ethanol 
administration
Previous studies indicate that serum and peritoneal
cytokines are derived from different sources [13,18].
Because peritoneal macrophages were used in the cellular
signaling studies reported here, it seemed appropriate to
also assess cytokine production in the peritoneal cavity.
Results of this analysis are shown in Figure 6. There were
some clear differences in the pattern of ethanol effects on
cytokine production as compared to effects on serum
cytokines. For example, the peritoneal IL-1 concentra-
tion was decreased by ethanol administration at all three
time points before LPS. The concentration of IL-6 was
decreased less by administration of ethanol 0.5 hr before
LPS than by administration 2 or 24 hr before. In contrast,
all three times of administration yielded similar inhibi-
tion in the serum. The concentration of IL-12 p40 in the
peritoneal cavity was decreased less when ethanol was
administered 24 hr before LPS than at the other times of
administration. In contrast, the concentrations in serum
were similar for all three times of administration. The
effects of ethanol at all times of administration were sim-
ilar for TNF- in serum and peritoneal fluid. It should be
noted that the much lower concentration of cytokines in
peritoneal lavage fluid than in serum may simply reflect
the unavoidable dilution of the peritoneal fluid during
the lavage process. The amount of dilution is not known,
but it may be sufficient that the actual concentrations in
the peritoneal cavity would be similar to those in serum.
Discussion
Results shown in this study demonstrate that LPS-induced
signaling through TLR4 is inhibited by ethanol in vivo in
a mouse model for binge drinking. Rapid isolation of
peritoneal macrophages allowed detection of the activa-
tion of all tested signaling parameters by LPS and any
inhibition caused by ethanol. The mechanism by which
ethanol disrupts signaling is not completely understood,
but studies conducted primarily in vitro suggest that etha-
nol disrupts movement of components of the TLR4 recep-
tor complex into lipid rafts and inhibits associated
Ethanol modulates production of some cytokines in peritoneal fluid even when administered 24 hr before LPS Figure 6
Ethanol modulates production of some cytokines in peritoneal fluid even when administered 24 hr before LPS. 
Mice were treated with ethanol (6 g/kg by gavage) at the indicated times before LPS, and blood and peritoneal fluid samples 
were obtained for analysis 2 hr after LPS. Values shown are means ± SEM (n = 5). Because of overlapping values, showing sta-
tistical results on the graphs is not practical. Major statistically significant outcomes are identified in the text of the results sec-
tion.BMC Immunology 2009, 10:49 http://www.biomedcentral.com/1471-2172/10/49
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receptor clustering, rearrangement of the actin cytoskele-
ton, and activation of the signaling cascade [19-22]. The
results presented here demonstrate that later signaling
events are also inhibited by ethanol and that this occurs in
vivo. Similar results were obtained by others following
acute ethanol administration to mice in vivo and stimula-
tion of cells with LPS ex vivo [23] and following acute eth-
anol exposure of human monocytes in culture [19].
Together, these results and the results reported here sug-
gest that inhibition of production of pro-inflammatory
cytokines by acute exposure to ethanol is a robust phe-
nomenon that is probably mediated directly by ethanol's
effect on ligand binding or events normally induced just
after ligand binding to the TLR4 receptor complex.
The inhibition of signaling was greatest 30 min after LPS
administration for ERK, p38, and c-Jun. This was the case
even though the kinetics of activation were not all the
same for these signaling molecules. This suggests that eth-
anol is most active with regard to signal disruption 1 hr
after administration (30 min after LPS). This is near the
time at which ethanol reaches maximum blood levels
after intragastric administration of the dosage used in this
study [14]. It was surprising that the LPS-induced translo-
cation of the p65 component of NF-B to the nucleus was
not affected by ethanol. Most of the cytokines affected by
ethanol require NF-B for activation, so it would be sur-
prising if inhibition of NF-B activation could not be
detected. Inhibition of LPS-induced p65 translocation has
been reported in human monocytes treated with ethanol
in vitro, but decreased phosphorylation of p65 (which
was not assessed in the present study) was found to be
more important [24]. It is not clear why no change in p65
translocation was observed here, but we have previously
reported inhibition of p65 translocation by acute ethanol
exposure in mice treated with polyinosinic polycytidylic
acid to activate TLR3 [8]. The same methodology and
materials were used in the present study, so it is unlikely
the current negative result can be explained as a technical
problem. However, the use of NF-B reporter mice clearly
demonstrated suppression of NF-B activation. It is possi-
ble that p65 enters the nucleus normally in ethanol
treated mice but decreased phosphorylation decreases its
transactivation function. It is also possible that NF-B
composed of subunits other than p65 is responsible for
activation of NF-B mediated gene expression and that
entry of these subunits into the nucleus is inhibited by
ethanol. These issues are under investigation, and results
will be reported in a separate publication.
The combination of decreased activation of AP-1 (as indi-
cated by decreased phosphorylation of c-Jun) and NF-B
would be expected to inhibit LPS-induced expression of
cytokines whose expression is dependent on these tran-
scription factors. This includes TNF- [12], IL-12 [25], IL-
1 [26], and IL-6 [27]. All of these cytokines were signifi-
cantly suppressed at one or more time points in the peri-
toneal cavity in ethanol-treated mice. The basis for the
increased production of IL-10 is not clear, but it does not
seem to involve a mechanism reported in human mono-
cytes in which ethanol increases LPS-induced p38 activa-
tion, leading to increased heme oxygenase 1, which
increases IL-10 gene expression [28]. In the present study,
enhanced IL-10 production was associated with sup-
pressed p38 activation. The basis for this difference is not
clear, but this could either represent a species difference
(human vs. mouse) or a difference in effects of LPS and/
or ethanol in vivo (present study) vs. in vitro [28].
The decreased pro-inflammatory cytokines and increased
IL-10 observed here would be expected to decrease resist-
ance to infection, and we have previously reported such a
decrease in mice treated by acute administration of etha-
nol [13]. Cytokines inhibited by ethanol in the present
study, such as IL-12, IL-6, and TNF- have been shown to
be important in innate resistance to infections [29-31].
Increased IL-10 concentrations would be expected to
decrease innate resistance to infections [32]. Furthermore,
this decrease in some pro-inflammatory cytokines is
observed even when ethanol is administered as much as
24 hr before immunological challenge. Thus, the time
frame during which the risk of infection is increased
might be at least 24 hr.
Differences were observed in the pattern of cytokine
expression and effects of ethanol when comparing con-
centrations of cytokines in the serum and peritoneal cav-
ity. For example, serum IL-1 was not inhibited
significantly at 2 hr following LPS by ethanol adminis-
tered 0.5, 2, or 24 hr before LPS. However, in the perito-
neal cavity there was significant inhibition 2 hr after LPS
caused by administration of ethanol at 0.5, 2, or 24 hr.
Other differences were also noted, which are consistent
with our previous conclusion that cytokines in the perito-
neal cavity and in the serum are derived predominantly
from different cells types which are affected differently
both by LPS and ethanol [33]. Some of these differences
could also be due to differences in the concentration, rate
of clearance, and concentrations of active metabolites of
ethanol in liver or spleen (sources for a substantial por-
tion of pro-inflammatory cytokines in serum) as com-
pared to peritoneal cavity. These issues are currently under
investigation. In any case, the changes in signaling in peri-
toneal macrophages and changes in cytokine production
in the peritoneal cavity are comparable, which is consist-
ent with the idea that decreased signaling is a major cause
of altered cytokine production.
The effects of ethanol at 0.5 or 2.0 hr would be consistent
with our previous findings suggesting direct action of eth-BMC Immunology 2009, 10:49 http://www.biomedcentral.com/1471-2172/10/49
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anol on macrophages, which requires that the ethanol is
present during stimulation with LPS to produce the effect
[21,22]. However, inhibition of the production of some
cytokines by ethanol administered 24 hr before LPS dem-
onstrates persistent effects as well. Ethanol is completely
cleared in this model within 12 hr [14], so effects that per-
sist 24 hr after dosing cannot represent direct action of
ethanol, but must represent relatively persistent effects on
cells. The mechanism for these effects is under investiga-
tion.
The results presented here indicate that activation of cellu-
lar signaling induced by LPS in peritoneal macrophages is
inhibited by ethanol in vivo. The magnitude of changes in
AUC values for signaling molecule activation and changes
in AUC values for cytokine concentration were generally
similar. Disparate amounts of change would not have
supported a cause-effect relationship between inhibition
of signaling and inhibition of cytokine production. How-
ever, the results shown here as well as abundant results
from published studies indicating that signaling inhibi-
tors decrease cytokine production [34-36], suggest that a
cause-effect relationship between inhibition of signaling
and inhibition of cytokine production is feasible. These
results were obtained using an animal model in which
ethanol has been demonstrated to decrease innate immu-
nity to infection [13], suggesting that the observed
changes are functionally relevant with regard to host
resistance as well.
Conclusion
The results shown here indicate that acute ethanol expo-
sure inhibits signalling through TLR4 in vivo in a manner
similar to that which has been demonstrated in vitro and
ex vivo. However, detecting inhibition of NF-B required
the use of reporter mice and was not successful when p65
(the most common subunit of activating NF-B het-
erodimers) was evaluated. The observation that ethanol
given 24 hr before LPS inhibits production of some
cytokines indicates a persistent effect of ethanol on cells




Female C57Bl/6 × C3H F1 (B6C3F1) mice were obtained
from Charles River Labs through the National Cancer
Institute's animal program. Mice were allowed to recover
from shipping stress for at least two weeks before use in
experiments at 8-16 weeks of age. They were housed 5 per
cage in a temperature and humidity controlled facility.
Sentinel mice housed in the same room were negative for
common mouse pathogens during the period of this
study. Animal care and use was conducted in accord with
the NIH Guide and the regulations of Mississippi State
University. The animal care and use program at MSU is
accredited by the American Association for Accreditation
of Laboratory Animal Care. Ethanol was administered by
gavage using a 32% solution (v/v) in tissue culture grade
sterile water. This has been shown to yield blood ethanol
concentrations relevant to binge drinking and not to cause
necrosis or other gross histopathological changes in the
gastrointestinal tract [14]. This model has been cited and
used by a number of other investigators. Peritoneal mac-
rophages were activated in vivo by intravenous adminis-
tration of lipopolysaccharide (LPS, Sigma Chemical Co.,
St. Louis, MO, from E. coli 0111:B4) at 60 g/mouse.
Evaluation of signalling
Cells for assessment of signaling were obtained at selected
times after LPS administration by peritoneal lavage using
7 ml of ice cold phosphate buffered saline with 1% bovine
serum albumin. The cell pellet from each mouse (after
centrifugation at 300 × g for 5 min) was then used for
analysis of signaling. Evaluation of p-c-Jun and NF-B
(p65) was done by preparing nuclear extracts as in our
previous study [37] and using western blot analysis with
antibodies to p-c-Jun and NF-B p65 from Santa Cruz Bio-
technology (Santa Cruz, CA). Secondary antibodies con-
jugated with horseradish peroxidase were obtained from
the same source. Bands were visualized using a chemilu-
minescence kit (Amerasham, Chalfont St. Giles, UK).
Images were obtained using a VersaDoc 3000 (BioRad,
Hercules, CA). Relative quantitation of band intensities
was accomplished as described previously using NIH
Image software [37]. Actin was used as a loading control
in these analyses. The quantity of phospho-p38 and phos-
pho-ERK (p-p38 and p-ERK) was determined using a cell
based assay kit (FACE, Active Motif, Carlsbad, CA).
NF-B reporter mice
Transgenic mice with a reporter construct consisting of a
luciferase gene with an NF-B dependent promoter were
produced by Carlsen and colleagues [38] and obtained
through Xenogen (Alameda, CA). Mice were treated with
ethanol 30 min before stimulation of NF-B activation.
Mice were treated with bacterial lipopolysaccharide (from
E. coli 0128:B12, Sigma Chemical Co., catalog #L2755) by
administering 60 g/mouse, intravenously. Two hr after
LPS, mice were anesthetized with 150 mg/kg ketamine
and 5 mg/kg xyalzine intraperitoneally. Mice were then
treated with luciferin (15 mg/kg, intraperitoneally), and
imaging was done 5-10 min later using an IVIS imager
(Xenogen, Alameda, CA).
Evaluation of cytokine concentrations
Cytokines in serum and peritoneal lavage fluid were ana-
lyzed by multiplexed bead array analysis using a kit from
BioRad and a Bioplex reader. Peritoneal lavage was done
initially by removing the skin from the abdomen withoutBMC Immunology 2009, 10:49 http://www.biomedcentral.com/1471-2172/10/49
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puncturing the membrane of the peritoneal cavity then
injecting 1 ml of ice cold phosphate buffered saline with
1% fetal bovine serum. The abdomen was massaged to
dislodge cells and mix, and a 25 g needle and syringe was
used remove the fluid (usually 0.7 ml of the original 1 ml
was obtained). Cytokines were assessed at various times
after challenge with LPS (indicated in figures).
Data analysis and statistics
Area under the curve values for cytokine expression over
time and activation of signaling molecules over time were
calculated by entering the data in Prism 4.0 software
(GraphPad, LaJolla, CA) and selecting area under the
curve in the analysis menu. Statistical comparisons were
done by Analysis of Variance (ANOVA) or Student's t test
(to compare 2 groups) at each time point, using Prism 4.0
software (GraphPad Software, LaJolla, CA).
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